{"Symbol": "ASRT", "AssetType": "Common Stock", "Name": "Assertio Therapeutics Inc", "Description": "Assertio Holdings, Inc., a commercial pharmaceutical company, provides medications in the areas of neurology, hospital, and pain and inflammation. The company is headquartered in Lake Forest, Illinois.", "CIK": "1808665", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "HEALTHCARE", "Industry": "DRUG MANUFACTURERS - SPECIALTY & GENERIC", "Address": "100 SOUTH SAUNDERS ROAD, LAKE FOREST, IL, UNITED STATES, 60045", "OfficialSite": "https://www.assertiotx.com", "FiscalYearEnd": "December", "LatestQuarter": "2025-09-30", "MarketCapitalization": "79408000", "EBITDA": "11002000", "PERatio": "None", "PEGRatio": "1.5", "BookValue": "16.49", "DividendPerShare": "None", "DividendYield": "None", "EPS": "-4.5", "RevenuePerShareTTM": "21.5", "ProfitMargin": "-0.211", "OperatingMarginTTM": "0.287", "ReturnOnAssetsTTM": "-0.0417", "ReturnOnEquityTTM": "-0.245", "RevenueTTM": "137354000", "GrossProfitTTM": "89926000", "DilutedEPSTTM": "-4.5", "QuarterlyEarningsGrowthYOY": "-0.188", "QuarterlyRevenueGrowthYOY": "0.694", "AnalystTargetPrice": "37.44", "AnalystRatingStrongBuy": "1", "AnalystRatingBuy": "3", "AnalystRatingHold": "0", "AnalystRatingSell": "0", "AnalystRatingStrongSell": "0", "TrailingPE": "-", "ForwardPE": "16.34", "PriceToSalesRatioTTM": "0.578", "PriceToBookRatio": "0.743", "EVToRevenue": "0.183", "EVToEBITDA": "5.54", "Beta": "0.729", "52WeekHigh": "15.15", "52WeekLow": "7.71", "50DayMovingAverage": "11.04", "200DayMovingAverage": "11.19", "SharesOutstanding": "6416800", "SharesFloat": "5707200", "PercentInsiders": "2.524", "PercentInstitutions": "29.207", "DividendDate": "None", "ExDividendDate": "None"}